Skip to content
SlushFund

Companies · USAspending parent record

ROCHE HOLDING AG

No confirmed stock ticker. 3 recipient records grouped under this USAspending parent (UEI WJHDT127L353).

Non-competed awards
$17.3M

obligated to date on 11 non-competed awards of $1M+ signed FY2024–26

Not recently updated

USAspendingas of Oct 3

Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.

Awards in our records
19

11 non-competed ($1M+) · 8 other ($10M+)

Not recently updated

USAspendingas of Oct 3
Largest award
$45.1M

obligated to date: 75A50325F80003, Department of Health and Human Services, signed FY2025

Not recently updated

USAspendingas of Oct 3
Member trades
No ticker

No confirmed stock ticker, so no member trades are matched to this company.

House Clerk + Senate eFDas of Oct 4
Not updated since Oct 3, 2026.Source: USAspending.gov · SEC EDGAR company tickers · House Clerk PTRs · Senate eFDCoverage: Contract awards FY2024–FY2026 · Ticker links FY2024–26 recipients · House 2021–2026 · Senate 2024–2026Methodology →

Federal contract awards in our records

Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.

What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.

Awards by fiscal year signed (obligated to date, not spending in the year)
Signed inNon-competed awardsObligated to dateOther awards $10M+Obligated to date
FY20244$6.2M3$57.8M
FY20254$6.8M4$128M
FY2026incomplete3$4.3M1$22.0M

FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.

FY2024–26 awards to ROCHE HOLDING AG, largest first (obligated to date)
Source
75A50325F80003Order under IDV 36F79723D0219OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULESGENENTECH USA, INCDepartment of Health and Human ServicesJan 29, 2025FY2025Full and open competition$45,106,864USAspending
75A50325F80036Order under IDV 36F79723D0219PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETSGENENTECH USA, INCDepartment of Health and Human ServicesSep 26, 2025FY2025Full and open competition$37,485,000USAspending
36C10G25F0005Order under IDV 36C10G24D0059TASK ORDER FOR BASE YEARFOUNDATION MEDICINE, INC.Department of Veterans AffairsOct 4, 2024FY2025Competed under SAP$24,000,010USAspending
36C10G24N0009Order under IDV 36C10G19D0032GENOMIC SEQUENCING TESTING SERVICESFOUNDATION MEDICINE, INC.Department of Veterans AffairsOct 3, 2023FY2024Full and open competition$22,374,867USAspending
36C10G26F0017Order under IDV 36C10G24D0059TASK ORDER FOR TUMOR MOLECULAR TESTING.FOUNDATION MEDICINE, INC.Department of Veterans AffairsSep 25, 2026FY2026Competed under SAP$22,000,000USAspending
75A50324F80013Order under IDV 36F79723D0219XOFLUZA (BALOXAVIR MARBOXIL)GENENTECH USA, INCDepartment of Health and Human ServicesSep 27, 2024FY2024Full and open competition$21,999,907USAspending
36C10G25F0019Order under IDV 36C10G24D0059MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORTFOUNDATION MEDICINE, INC.Department of Veterans AffairsSep 29, 2025FY2025Competed under SAP$21,581,260USAspending
36C24824F0003Order under IDV V797P7347ACOST PER TESTROCHE DIAGNOSTICS CORPORATIONDepartment of Veterans AffairsOct 1, 2023FY2024Full and open competition$13,392,079USAspending
36C24725C0053MOLECULAR ANALYZER REAGENTS & MAINTENANCEROCHE DIAGNOSTICS CORPORATIONDepartment of Veterans AffairsMar 7, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$1,965,106USAspending
W81K0225FA154Order under IDV W81K0225DA021REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM.ROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseSep 18, 2025FY2025Not competedOnly one source-other (FAR 6.302-1 other)$1,947,948USAspending
W81K0224F0124Order under IDV W81K0220D0016FY25 DELIVERY ORDER FOR MADIGAN ARMY MEDICAL CENTER FOR ROCHE TOTAL LABORATORY AUTOMATION LINE AND 3 COBAS 8000ROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseSep 17, 2024FY2024Not available for competitionOnly one source-other (FAR 6.302-1 other)$1,831,970USAspending
HT001426FE065Order under IDV HT001425A0014VENTANA BENCHMARK STAINS, REAGENTS, SUPPORTROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseJun 1, 2026FY2026Not competed under SAPSAP non-competition (FAR 13)$1,650,362USAspending
HT001425F0052Order under IDV HT001425A0014SIX MONTHS SLIDE STAINING REAGENT RENTALROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseJun 25, 2025FY2025Not competed under SAPSAP non-competition (FAR 13)$1,615,681USAspending
HT001424F0075Order under IDV HT001421A0001IMMUNOHISTOCHEMISTRY ANTIBODIES, SPECIAL STAIN REAGENTS, AND ROUTINE H&E REAGENTSROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseMar 25, 2024FY2024Not competed under SAPSAP non-competition (FAR 13)$1,602,294USAspending
HT001424F0152Order under IDV HT001421A00016 MONTHS SUPPLIES DROP SHIP APROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseSep 27, 2024FY2024Not competed under SAPSAP non-competition (FAR 13)$1,602,294USAspending
HT001426FE015Order under IDV HT001425A0014PROCUREMENT OF TISSUE STAINING AND PROCESSING CAPABILITIESROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseJan 27, 2026FY2026Not competed under SAPSAP non-competition (FAR 13)$1,602,294USAspending
36C24125N0745Order under IDV 36C24124A0052VENTANA HISTOLOGY REAGENTSROCHE DIAGNOSTICS CORPORATIONDepartment of Veterans AffairsApr 9, 2025FY2025Not competed under SAPSAP non-competition (FAR 13)$1,240,478USAspending
HT941024P0092THE ANNUAL COMMITTED VOLUMES TO EXECUTE THIS CONTRACT IS 11,200 SLIDES PER YEAR FOR IHC AND 1,500 SLIDES FOR SPECIAL STAINS.ROCHE DIAGNOSTICS CORPORATIONDepartment of DefenseJun 12, 2024FY2024Not competed under SAPSAP non-competition (FAR 13)$1,204,381USAspending
36C25926N0173Order under IDV 36C25923A0007VISN 19 GENMARK EPLEX REAGENTS AND MAINTENANCEROCHE DIAGNOSTICS CORPORATIONDepartment of Veterans AffairsDec 23, 2025FY2026Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,051,808USAspending

FY2024–26 awards to ROCHE HOLDING AG, largest first (obligated to date)

  • 75A50325F80003Order under IDV 36F79723D0219OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES
    GENENTECH USA, INC
    Signed
    Jan 29, 2025FY2025
    Competition
    Full and open competition
    Obligated to date
    $45,106,864
  • 75A50325F80036Order under IDV 36F79723D0219PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
    GENENTECH USA, INC
    Signed
    Sep 26, 2025FY2025
    Competition
    Full and open competition
    Obligated to date
    $37,485,000
  • 36C10G25F0005Order under IDV 36C10G24D0059TASK ORDER FOR BASE YEAR
    FOUNDATION MEDICINE, INC.
    Signed
    Oct 4, 2024FY2025
    Competition
    Competed under SAP
    Obligated to date
    $24,000,010
  • 36C10G24N0009Order under IDV 36C10G19D0032GENOMIC SEQUENCING TESTING SERVICES
    FOUNDATION MEDICINE, INC.
    Signed
    Oct 3, 2023FY2024
    Competition
    Full and open competition
    Obligated to date
    $22,374,867
  • 36C10G26F0017Order under IDV 36C10G24D0059TASK ORDER FOR TUMOR MOLECULAR TESTING.
    FOUNDATION MEDICINE, INC.
    Signed
    Sep 25, 2026FY2026
    Competition
    Competed under SAP
    Obligated to date
    $22,000,000
  • 75A50324F80013Order under IDV 36F79723D0219XOFLUZA (BALOXAVIR MARBOXIL)
    GENENTECH USA, INC
    Signed
    Sep 27, 2024FY2024
    Competition
    Full and open competition
    Obligated to date
    $21,999,907
  • 36C10G25F0019Order under IDV 36C10G24D0059MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORT
    FOUNDATION MEDICINE, INC.
    Signed
    Sep 29, 2025FY2025
    Competition
    Competed under SAP
    Obligated to date
    $21,581,260
  • 36C24824F0003Order under IDV V797P7347ACOST PER TEST
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Oct 1, 2023FY2024
    Competition
    Full and open competition
    Obligated to date
    $13,392,079
  • 36C24725C0053MOLECULAR ANALYZER REAGENTS & MAINTENANCE
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Mar 7, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $1,965,106
  • W81K0225FA154Order under IDV W81K0225DA021REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM.
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Sep 18, 2025FY2025
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $1,947,948
  • W81K0224F0124Order under IDV W81K0220D0016FY25 DELIVERY ORDER FOR MADIGAN ARMY MEDICAL CENTER FOR ROCHE TOTAL LABORATORY AUTOMATION LINE AND 3 COBAS 8000
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Sep 17, 2024FY2024
    Competition
    Not available for competitionOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $1,831,970
  • HT001426FE065Order under IDV HT001425A0014VENTANA BENCHMARK STAINS, REAGENTS, SUPPORT
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Jun 1, 2026FY2026
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,650,362
  • HT001425F0052Order under IDV HT001425A0014SIX MONTHS SLIDE STAINING REAGENT RENTAL
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Jun 25, 2025FY2025
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,615,681
  • HT001424F0075Order under IDV HT001421A0001IMMUNOHISTOCHEMISTRY ANTIBODIES, SPECIAL STAIN REAGENTS, AND ROUTINE H&E REAGENTS
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Mar 25, 2024FY2024
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,602,294
  • HT001424F0152Order under IDV HT001421A00016 MONTHS SUPPLIES DROP SHIP AP
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Sep 27, 2024FY2024
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,602,294
  • HT001426FE015Order under IDV HT001425A0014PROCUREMENT OF TISSUE STAINING AND PROCESSING CAPABILITIES
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Jan 27, 2026FY2026
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,602,294
  • 36C24125N0745Order under IDV 36C24124A0052VENTANA HISTOLOGY REAGENTS
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Apr 9, 2025FY2025
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,240,478
  • HT941024P0092THE ANNUAL COMMITTED VOLUMES TO EXECUTE THIS CONTRACT IS 11,200 SLIDES PER YEAR FOR IHC AND 1,500 SLIDES FOR SPECIAL STAINS.
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Jun 12, 2024FY2024
    Competition
    Not competed under SAPSAP non-competition (FAR 13)
    Obligated to date
    $1,204,381
  • 36C25926N0173Order under IDV 36C25923A0007VISN 19 GENMARK EPLEX REAGENTS AND MAINTENANCE
    ROCHE DIAGNOSTICS CORPORATION
    Signed
    Dec 23, 2025FY2026
    Competition
    Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,051,808
19 awards. Source: USAspending.gov award records.
Recipient records grouped under this company (3)

USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to ROCHE HOLDING AG; the stock link below is made per recipient.

  • ROCHE DIAGNOSTICS CORPORATION12 awards · 11 non-competed, $17.3M obligated to date
  • FOUNDATION MEDICINE, INC.4 awards
  • GENENTECH USA, INC3 awards

Stock ticker

Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.

Members of Congress who reported trading this stock

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.

Looking for agency-level shares? See non-competed share by agency.